Trial Profile
A Study to Evaluate the Safety of Sugammadex Neuromuscular Blockade Reversal in Patients With End Stage Renal Disease who Had Renal Transplantation
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Mar 2016
Price :
$35
*
At a glance
- Drugs Sugammadex (Primary)
- Indications Neuromuscular blockade
- Focus Adverse reactions
- 01 Mar 2016 New trial record